TLPPF supply chain intelligence for Telix Pharmaceuticals Ltd: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Telix Pharmaceuticals Ltd (TLPPF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | 72% | Reciprocal relationship from ATNM graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from ATNM… |
| ATNM | Actinium Pharmaceuticals, Inc. | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| BSX | Boston Scientific Corporation | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and re… |
| BTAIQ | BTAIQ | 72% | Reciprocal relationship from BTAIQ graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and … |
| BTAIQ | BTAIQ | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| CATX | Perspective Therapeutics, Inc. | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| CATX | Perspective Therapeutics, Inc. | 72% | Reciprocal relationship from CATX graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and r… |
| CLRB | Cellectar Biosciences, Inc. | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| CLRB | Cellectar Biosciences, Inc. | 72% | Reciprocal relationship from CLRB graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from CLRB graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse su… |
| RADX | Radiopharm Theranostics Limited | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| RADX | Radiopharm Theranostics Limited | 72% | Reciprocal relationship from RADX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from RADX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from RADX… |
| REGN | Regeneron Pharmaceuticals, Inc. | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| REGN | Regeneron Pharmaceuticals, Inc. | 72% | Reciprocal relationship from REGN graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from REGN graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse su… |
| SNSE | Sensei Biotherapeutics, Inc. | 72% | Reciprocal relationship from SNSE graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and r… |
| SNSE | Sensei Biotherapeutics, Inc. | 72% | y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to securing a reliable supply, we are also comm… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| ATNM | Actinium Pharmaceuticals, Inc. | 72% | Reciprocal relationship from ATNM graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize … |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from BSX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from BSX gr… |
| BSX | Boston Scientific Corporation | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| BTAIQ | BTAIQ | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| BTAIQ | BTAIQ | 72% | Reciprocal relationship from BTAIQ graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from BTAIQ graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from BT… |
| CATX | Perspective Therapeutics, Inc. | 72% | Reciprocal relationship from CATX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from CATX graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain,… |
| CATX | Perspective Therapeutics, Inc. | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| CLRB | Cellectar Biosciences, Inc. | 72% | Reciprocal relationship from CLRB graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize … |
| CLRB | Cellectar Biosciences, Inc. | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| RADX | Radiopharm Theranostics Limited | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| RADX | Radiopharm Theranostics Limited | 72% | Reciprocal relationship from RADX graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize … |
| REGN | Regeneron Pharmaceuticals, Inc. | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| REGN | Regeneron Pharmaceuticals, Inc. | 72% | Reciprocal relationship from REGN graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from REGN graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from REGN… |
| SNSE | Sensei Biotherapeutics, Inc. | 72% | her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in our ability to anticipate and respond to … |
| SNSE | Sensei Biotherapeutics, Inc. | 72% | Reciprocal relationship from SNSE graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from SNSE graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from SNSE… |
| TLX | Telix Pharmaceuticals Limited | 72% | Reciprocal relationship from TLX graph: Reciprocal relationship from TLPPF graph: Reciprocal relationship from TLX graph: Reciprocal relationship from TLPPF graph: . The bonds are convertible into fu… |
| TLX | Telix Pharmaceuticals Limited | 72% | . The bonds are convertible into fully paid ordinary shares in Telix Pharmaceuticals Limited. The initial conversion price of the convertible bonds is $ per share, subject to anti-dilution adjustment… |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| RADX | Radiopharm Theranostics Limited | 100.00 | 1 | ['customer', 'supplier'] |
| CLRB | Cellectar Biosciences, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BTAIQ | BioXcel Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BSX | Boston Scientific Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| REGN | Regeneron Pharmaceuticals, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| SNSE | Sensei Biotherapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ATNM | Actinium Pharmaceuticals, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| TLX | Telix Pharmaceuticals Limited | 100.00 | 1 | ['customer'] |
| EDSA | Edesa Biotech, Inc. | 50.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 50.00 | 2 | |
| ORANY | ORANGE | 50.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 50.00 | 2 | |
| RGNX | REGENXBIO Inc. | 50.00 | 2 | |
| ALLR | Allarity Therapeutics, Inc. | 50.00 | 2 | |
| CVRX | CVRx, Inc. | 50.00 | 2 | |
| FATE | Fate Therapeutics, Inc. | 50.00 | 2 | |
| ALC | Alcon Inc. | 50.00 | 2 | |
| DRTSW | Alpha Tau Medical Ltd. | 50.00 | 2 | |
| CNSP | CNS Pharmaceuticals, Inc. | 50.00 | 2 |